We are live on ! Find out more
MP

MVM Partners Portfolio holdings

AUM $10.8M
1-Year Est. Return 61.97%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+61.97%
3 Year Est. Return
+27.98%
5 Year Est. Return
10 Year Est. Return
AUM
$294M
AUM Growth
Cap. Flow
+$302M
Cap. Flow %
102.83%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$258M
2
OPTN
OptiNose
OPTN
+$37M
3
MDXH icon
MDxHealth
MDXH
+$6.51M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNA
1
DELISTED
Paragon 28, Inc.
FNA
$261M 88.84%
+13,659,625
New +$258M
OPTN
2
DELISTED
OptiNose
OPTN
$26.8M 9.13%
+973,684
New +$37M
MDXH icon
3
MDxHealth
MDXH
$21.1M
$5.95M 2.03%
+916,666
New +$6.51M

Similar funds

MVM Partners's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for MVM Partners, which disclosed 3 positions worth $294M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Paragon 28, Inc.: 13,659,625 shares worth $261M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • MVM Partners's largest Q4 2022 buy was Paragon 28, Inc.: 13,659,625 shares worth $261M.
  • MVM Partners's ten largest holdings make up 100% of its $294M portfolio in Q4 2022.
  • MVM Partners disclosed 3 positions in Q4 2022, its first 13F filing on record.

Based on MVM Partners's 13F filing for Q4 2022, filed 13 Feb 2023.